BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Yuan XH, Wang SQ, Zhao W, Chen XB, Yu B. FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. Eur J Med Chem 2021;214:113218. [PMID: 33540357 DOI: 10.1016/j.ejmech.2021.113218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao T, Wang Y, Hu K, Lian G, Jin G. Nitrogen-boron eight-ring rigid cis/trans BODIPY-pyrimidine isomers for in vivo and in vitro fluorescence target recognition and evaluation of inhibitory activity. Dyes and Pigments 2022;201:110204. [DOI: 10.1016/j.dyepig.2022.110204] [Reference Citation Analysis]
2 Barreca M, Ingarra AM, Raimondi MV, Spanò V, De Franco M, Menilli L, Gandin V, Miolo G, Barraja P, Montalbano A. Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells. European Journal of Medicinal Chemistry 2022;237:114399. [DOI: 10.1016/j.ejmech.2022.114399] [Reference Citation Analysis]
3 Jin X, Piao HR, Pannecouque C, De Clercq E, Zhuang C, Chen FE. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel. Eur J Med Chem 2021;226:113868. [PMID: 34583311 DOI: 10.1016/j.ejmech.2021.113868] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abourehab MAS, Alqahtani AM, Youssif BGM, Gouda AM. Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism. Molecules 2021;26:6677. [PMID: 34771085 DOI: 10.3390/molecules26216677] [Reference Citation Analysis]
5 El-dydamony NM, Abdelnaby RM, Abdelhady R, Ali O, Fahmy MI, R. Fakhr Eldeen R, Helwa AA. Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:895-911. [DOI: 10.1080/14756366.2022.2051022] [Reference Citation Analysis]
6 Wang S, Chen F. Small-molecule MDM2 inhibitors in clinical trials for cancer therapy. European Journal of Medicinal Chemistry 2022;236:114334. [DOI: 10.1016/j.ejmech.2022.114334] [Reference Citation Analysis]
7 Wang W, Yang Z, Li A, Liu Q, Sun Y, Gu W. Design, synthesis, anticancer activity and mechanism studies of novel 2-amino-4-aryl-pyrimidine derivatives of ursolic acid. New J Chem . [DOI: 10.1039/d1nj05294b] [Reference Citation Analysis]
8 Mohammadi M, Bagheri L, Badreldin A, Fatehi P, Pakzad L, Suntres Z, van Wijnen AJ. Biological Effects of Gyrophoric Acid and Other Lichen Derived Metabolites, on Cell Proliferation, Apoptosis and Cell Signaling pathways. Chem Biol Interact 2022;351:109768. [PMID: 34864007 DOI: 10.1016/j.cbi.2021.109768] [Reference Citation Analysis]
9 Ling Y, Hao ZY, Liang D, Zhang CL, Liu YF, Wang Y. The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. Drug Des Devel Ther 2021;15:4289-338. [PMID: 34675489 DOI: 10.2147/DDDT.S329547] [Reference Citation Analysis]
10 Mohi El-deen EM, Anwar MM, El-gwaad AAA, Karam EA, El-ashrey MK, Kassab RR. Novel Pyridothienopyrimidine Derivatives: Design, Synthesis and Biological Evaluation as Antimicrobial and Anticancer Agents. Molecules 2022;27:803. [DOI: 10.3390/molecules27030803] [Reference Citation Analysis]
11 Yang W, Xuan B, Li X, Si H, Chen A. Therapeutic potential of 1,2,3-triazole hybrids for leukemia treatment. Arch Pharm (Weinheim) 2022;:e2200106. [PMID: 35532286 DOI: 10.1002/ardp.202200106] [Reference Citation Analysis]
12 Huang W, Wang Y, Xu S, Qiao H, Cheng H, Wang L, Liu S, Tian Q, Wang R, Wang H, Bi Y. Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114207] [Reference Citation Analysis]
13 Bistrović Popov A, Vianelo R, Grbčić P, Sedić M, Pavelić SK, Pavelić K, Raić-Malić S. Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation. Molecules 2021;26:3334. [PMID: 34206076 DOI: 10.3390/molecules26113334] [Reference Citation Analysis]
14 Khan S, Kale M, Siddiqui F, Nema N. Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein. Digital Chinese Medicine 2021;4:102-19. [DOI: 10.1016/j.dcmed.2021.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Farouk O, Ibrahim MA, El-gohary NM. Synthesis, chemical reactivity and biological evaluation of the novel 2-[(1-chloro-3-oxoprop-1-en-1-yl)amino]-4-(4-methoxyphenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile. Synthetic Communications 2021;51:2991-3003. [DOI: 10.1080/00397911.2021.1958231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]